epigallocatechin gallate has been researched along with Sexually Transmitted Disease, Viral in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ho, WZ; Li, JL; Li, XD; Liu, H; Liu, JB; Liu, MQ; Ma, TC; Wang, X; Xiao, QH; Zhou, L; Zhou, RH; Zhou, W; Zhuang, K | 1 |
1 other study(ies) available for epigallocatechin gallate and Sexually Transmitted Disease, Viral
Article | Year |
---|---|
Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques.
Topics: Animals; Antiviral Agents; Catechin; CD4 Antigens; Cell Movement; Disease Transmission, Infectious; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Macaca; Macrophages; Protein Binding; Risk; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tea | 2018 |